Wordt geladen...
Endothelin antagonists in subarachnoid hemorrhage: what next?
In the previous issue of Critical Care, Ma and colleagues perform a meta-analysis of five randomized, clinical trials of endothelin antagonists in patients with aneurysmal subarachnoid hemorrhage. There are four trials using clazosentan and one trial with TAK-044. These studies show that endothelin...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672573/ https://ncbi.nlm.nih.gov/pubmed/23146320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc11822 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|